LODH Private Equity Partners lombardodier.com/en/independent-asset-managers/financial-products/alternative-investments/private-equity.html

LODH Private Equity Partners is the private equity arm of Lombard Odier Darier Hentsch, a private banking company. LODH Private Equity Partners provides a broad range of investment solutions from products, bespoke investment programs (mandates) to fund recommendations, administration, reporting and custody support for private equity investments, and personalized advisory services.

LODH Private Equity Partners is the private equity arm of Lombard Odier Darier Hentsch, a private banking company. LODH Private Equity Partners provides a broad range of investment solutions from products, bespoke investment programs (mandates) to fu...Show all

See All Exits Recent Exits

Phone:

Fax:

Rue de la Corraterie 11
P.O. Box 5215
 1211
 Switzerland

LODH Private Equity Partners - Investments & Acquisitions

Show Real Data
See all Recent Investments
Date Company Round Amount Co-investors
2010-11-17SomaLogicSeries E$15MAffentranger Associates, Mitsui & Co. Global Investment, NEC Corporation, NewWest Capital Partners, Otsuka Holdings, Otsuka Pharmaceutical, ProQuest Investments, Quest Diagnostics, Skye Investment Advisors, and Sumitomo Bakelite
2010-09-09Sunesis PharmaceuticalsPIPE - III$15.5MAbingworth, Alta Partners, Bay City Capital, Biotechnology Value Fund, Deerfield Management, Domain Associates, International Biomedicine Management Partners, International Biotechnology Trust, Mayfield Fund, Merlin Nexus, New Enterprise Associates, Nextech Venture, NMT Management AG - New Medical Technologies, OpusPoint Partners, Skyline Ventures, SV Life Sciences, Venrock, Vision Capital Advisors, and Warburg Pincus
2010-05-07Intarcia TherapeuticsSeries B - IIAdams Street Partners, Affentranger Associates, Alta Partners, Bay City Capital, Brentwood Associates, Charter Life Sciences, Charter Venture Capital, Delphi Ventures, GGV Capital, Glynn Capital Management, Greenspring Associates, InterWest Partners, New Enterprise Associates, New Leaf Venture Partners, Omega Advisors, Omega Fund Management, Pictet Group, Quilvest Private Equity, SB Life Science Ventures, and Venrock
2009-12-14Intarcia TherapeuticsGrowth Equity$7MAdams Street Partners, Affentranger Associates, Alta Partners, Bay City Capital, Brentwood Associates, Charter Life Sciences, Charter Venture Capital, Delphi Ventures, GGV Capital, Glynn Capital Management, Greenspring Associates, InterWest Partners, New Enterprise Associates, New Leaf Venture Partners, Omega Advisors, Omega Fund Management, Pictet Group, Quilvest Private Equity, SB Life Science Ventures, and Venrock
2008-04-07Paratek PharmaceuticalsPIPE$40MAisling Capital, Bio Fund Management, BioVeda Capital, D.E. Shaw & Co., HBM BioVentures, HBM Partners, Hercules Capital, Nomura Holdings, and Novartis Venture Funds
See all 5 investments